Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Director | May 18, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date May 18, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, without par valueSEC Table I · non-derivative | Direct | 4,325,000 |
Reported balance
After 2026-05-18 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-05-18 · Purchase · Acquired 100,000 · Balance 4,325,000 |
| Common Stock, without par valueSEC Table I · non-derivative | Direct | 4,425,000 |
Reported balance
After 2026-05-20 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2026-05-20 · Purchase · Acquired 97,515 · Balance 4,425,000 |
| Common stock, without par valueSEC Table I · non-derivative | Direct | 4,327,485 |
Reported balance
After 2026-05-19 transaction · row 2
1 source rowRow 2 · 2026-05-19 · Purchase · Acquired 2,485 · Balance 4,327,485 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 100,000 | $0.35 | $35,000.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 9 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 100,000 | $1.16 | $115,670.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 8 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 100,000 | $0.45 | $45,000.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 7 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 100,000 | $1.16 | $115,670.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 6 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 100,000 | $0.55 | $55,000.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 5 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 100,000 | $1.16 | $115,670.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 4 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 100,000 | $0.65 | $65,000.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 3 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 100,000 | $1.16 | $115,670.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 2 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 100,000 | $0.75 | $75,000.00 |
DisclosureSEC source: 0001171843-21-002447 · ownership.xml · nonDerivative · entry 1 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 20:53 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseWarrant · Derivative | 625,000 | Not disclosed Strike: $0.16 | Not disclosed |
DisclosureSEC source: 0000905718-20-000734 · zomedica_frm4jul72020.xml · derivative · entry 2 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock, without par value · 625,000 shares Expires 2022-07-07 F1 · price: Securities were issued pursuant to an underwritten public offering. Each share of common stock was sold together with one Series D warrant to purchase one share of common stock. Read SEC document |
| July 07, 2020 Filed Jul 7, 2020 20:53 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 625,000 | $0.16 | $100,000.00 |
DisclosureSEC source: 0000905718-20-000734 · zomedica_frm4jul72020.xml · nonDerivative · entry 1 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001791 · ownership.xml · derivative · entry 1 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares, without par value · 250,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 22:22 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-19-000712 · ownership.xml · derivative · entry 1 POWERS JOHNNY D · CIK 0001134545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Shares, without par value · 1,000,000 shares Expires 2021-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On August 16, 2019, the Issuer granted to Dr. Powers stock options to acquire up to an aggregate of 1,000,000 common shares of the Issuer pursuant to the Issuer's stock option plan. All of the stock options are fully vested and are exercisable for a period of two years from the date of grant. 500,000 of the stock options are exercisable at a price of US$0.26 per share, 100,000 of the stock options are exercisable at a price of US$0.35 per share, 100,000 of the stock options are exercisable at a price of US$0.45 per share, 100,000 of the stock options are exercisable at a price of US$0.55 per share, 100,000 of the stock options are exercisable at a price of US$0.65 per share and 100,000 of the stock options are exercisable at a price of US$0.75 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.